For ashwagandha, insufficient safety data exist for lactationgenerally, it should be avoided
Retatrutide, which would be Lilly's third obesity drug on the market if the Food and Drug Administration approves it, met both A1C- and weight-reduction goals in a Phase 3 trial of people with hard-to-control diabetes
The data you generate today could become the foundation for tomorrow's breakthroughs
Patients interested in complementary approaches should discuss these openly with their GP to ensure safe, coordinated care
Risk factors for diabetic peripheral neuropathy, peripheral artery disease, and foot deformity among the population with diabetes in Beijing, China: A multicenter, cross-sectional study
Shipping Rates Free Express Shipping Orders over $200 AUD Flat Rate Express Shipping $14.95 AUD for orders under $200 Delivery Times Metro Areas: 24 business days Regional Areas: 35 business days Delivery timeframes are estimates provided by Australia Post and may vary depending on your location and seasonal demand